INDICATIONS FOR USE: The RECELL® Autologous Cell Harvesting Device is indicated for the treatment of acute thermal burn wounds. The RECELL device is used by an appropriately-licensed healthcare professional at the patient’s point of care to prepare autologous RES® Regenerative Epidermal Suspension for direct application to acute partial-thickness thermal burn wounds in patients 18 years of age and older or application in combination with meshed autografting for acute full-thickness thermal burn wounds in pediatric and adult patients.
- Forums
- ASX - By Stock
- AVH
- RE: BARDA Contract to Advance Development of RECELL® System in Soft Tissue Reconstruction
RE: BARDA Contract to Advance Development of RECELL® System in Soft Tissue Reconstruction, page-8
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
|
|||||
Last
$2.70 |
Change
0.200(8.00%) |
Mkt cap ! $187.0M |
Open | High | Low | Value | Volume |
$2.51 | $2.81 | $2.51 | $2.547M | 942.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 36 | $2.69 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.75 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 36 | 2.690 |
2 | 10750 | 2.680 |
1 | 55 | 2.670 |
2 | 2061 | 2.660 |
2 | 7403 | 2.650 |
Price($) | Vol. | No. |
---|---|---|
2.760 | 1999 | 1 |
2.800 | 4500 | 2 |
2.810 | 1000 | 1 |
2.850 | 7012 | 3 |
2.860 | 300 | 1 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |